These disorders include a higher degree of endothelial dysfunction, reduced plasma nitric oxide (NO) levels due to a suppressed L-arginine/endothelial nitric oxide synthase (eNOS) pathway, an increased level of reactive oxygen species (ROS), increased leukocyte adhesion to the vascular wall, and an inflammatory response in the vasculature. This evidence concerns the gene NOS3 and endothelial dysfunction.